Gleevec: 25 Years
Celebrating the 25th anniversary of Gleevec, the revolutionary drug that turned a once-lethal cancer into a manageable condition.
All Stories
Gleevec: Reflections from former patients
As we reflect on the 25th anniversary of the FDA approval of Gleevec, former patients tell of how the cancer drug changed their lives.
Innovations in nursing education
Susan Bakewell-Sachs, Ph.D., RN, FAAN, is passionate about the advanced education and specialized expertise that define modern practice at the OHSU School of Nursing.
Creating a world-class care experience for cancer patients
Brian Druker, M.D., explores the impact of Phil and Penny Knight’s historical $2 billion gift to the Knight Cancer Institute and envisions what a truly world-class patient experience can be.
In conversation: A friendship built from diabetes care
Farahnaz Joarder, M.D., has been seeing Lynn Kauffman to help her manage her type 1 diabetes care for nearly two decades. The two have a strong working relationship that has developed into a friendship over the years.
Family grateful to OHSU for treating child’s rare cataracts
When Sam and Hannah Amis’ son was diagnosed with pediatric cataracts, they knew the OHSU Casey Eye Institute was the best place for care.
